DIAGNOSING LYMPHOPROLIFERATIVE DISEASE VIRUS IN LIVE WILD TURKEYS (MELEAGRIS GALLOPAVO) USING WHOLE BLOOD

2015 ◽  
Vol 46 (4) ◽  
pp. 806-814 ◽  
Author(s):  
Katrina Alger ◽  
Elizabeth Bunting ◽  
Krysten Schuler ◽  
Jarra Jagne ◽  
Christopher M. Whipps
2019 ◽  
Vol 63 (3) ◽  
pp. 506
Author(s):  
Amanda M. MacDonald ◽  
John R. Barta ◽  
Michelle McKay ◽  
Stéphane Lair ◽  
Rozenn Le Net ◽  
...  

2019 ◽  
Vol 55 (1) ◽  
pp. 113 ◽  
Author(s):  
Amanda M. MacDonald ◽  
Claire M. Jardine ◽  
Jeff Bowman ◽  
Leonardo Susta ◽  
Nicole M. Nemeth

PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0122644 ◽  
Author(s):  
Jesse M. Thomas ◽  
Andrew B. Allison ◽  
Edward C. Holmes ◽  
Jamie E. Phillips ◽  
Elizabeth M. Bunting ◽  
...  

2019 ◽  
Vol 56 (6) ◽  
pp. 915-920
Author(s):  
Kevin D. Niedringhaus ◽  
Nicole M. Nemeth ◽  
Holly S. Sellers ◽  
Justin D. Brown ◽  
Heather M. A. Fenton

Multiple oncogenic viruses, including lymphoproliferative disease virus (LPDV) and reticuloendotheliosis virus (REV), have been detected in wild turkeys ( Meleagris gallopavo). The prevalence of infection with these viruses appears to be more common than overt disease; thus, data on the manifestation of associated disease in wild turkeys are scarce. Diagnostic records from wild turkeys submitted to the Southeastern Cooperative Wildlife Disease Study from 1980 to 2017 were reviewed to identify cases of neoplasia. Neoplasia was reported in 59 of 851 (6.9%) wild turkeys submitted. Of the cases of neoplasia tested by polymerase chain reaction, LPDV was detected in 34 of 58 (59%), REV in 10 of 39 (26%), both viruses in 3 of 39 (8%), and no retroviruses detected in 5 of 39 (13%) turkeys. The most common gross lesions observed among turkeys with neoplasms were emaciation (30/40; 75%); nodules in the skin (26/59; 44%), liver (17/59; 29%), or spleen (9/59; 15%); and splenomegaly (14/59; 24%). Microscopically, nodules were composed of pleomorphic round cells with large eccentric nuclei and prominent nucleoli resembling lymphocytes or lymphoblasts (57/59; 97%) except for 2 cases, one of myeloid cell origin and the other with primarily spindloid cells. This study indicates the need to characterize the pathogenesis and potential health threat posed by REV and LPDV to wild turkeys. Experimental infection studies and the development of additional diagnostic tests to confirm the role of retroviruses in lymphoproliferative disease are warranted.


2014 ◽  
Vol 41 (7) ◽  
pp. 545 ◽  
Author(s):  
Britney Niedzielski ◽  
Jeff Bowman

Context In an era of rapid environmental change, many species are shifting their distributions. As temperate-zone species’ expand their ranges north, different and potentially severe limiting factors may begin to affect their ability to survive and reproduce. The wild turkey (Meleagris gallopavo) is one example of a species undergoing rapid northern expansion. Aims An improved understanding of wild turkey demography at the species’ northern range periphery would facilitate effective management of this important game species. Therefore, we undertook a study to evaluate survival, causes of mortality, and behavioural strategies that may govern survival of female wild turkeys. Methods We captured 53 female wild turkeys, and used backpack transmitters to monitor their individual fates during 2012–13. Key results The annual survival estimate was 0.37 (95% CI: 0.25–0.55), with the lowest seasonal survival in the winter. The most frequent cause of mortality was mammalian predation, predominately by coyotes (Canis latrans). Age, proximity to supplemental food, and habitat use did not affect risk of mortality. Conclusions Northern wild turkeys in our study exhibited lower survival and suffered higher predation than did populations in the species’ historic range. Despite our findings, the wild turkey has expanded its range northwards and continues to exist in these peripheral areas. This may be due to high productivity or a source–sink dynamic, whereby high mortality is offset by immigration from the south. Implications The low survival and high predation of wild turkeys in the north must be considered when developing management strategies, particularly if interest exists in translocating turkeys farther north. Further research is needed to better understand whether northern turkey populations persist as sinks.


2015 ◽  
Vol 14 (3) ◽  
pp. 447-472 ◽  
Author(s):  
Haemish I.A.S. Melville ◽  
Warren C. Conway ◽  
Michael L. Morrison ◽  
Christopher E. Comer ◽  
Jason B. Hardin

Blood ◽  
2001 ◽  
Vol 97 (5) ◽  
pp. 1165-1171 ◽  
Author(s):  
Servi J. C. Stevens ◽  
Erik A. M. Verschuuren ◽  
Inge Pronk ◽  
Wim van der Bij ◽  
Martin C. Harmsen ◽  
...  

Posttransplant lymphoproliferative disease (PTLD) is a frequent and severe Epstein-Barr virus (EBV)–associated complication in transplantation recipients that is caused by iatrogenic suppression of T-cell function. The diagnostic value of weekly EBV DNA load monitoring was investigated in prospectively collected unfractionated whole blood and serum samples of lung transplantation (LTx) recipients with and without PTLD. In PTLD patients, 78% of tested whole blood samples were above the cut-off value of quantitative competitive polymerase chain reaction (Q-PCR) (greater than 2000 EBV DNA copies per mL blood), with the majority of patients having high viral loads before and at PTLD diagnosis. Especially in a primary EBV-infected patient and in patients with conversion of immunosuppressive treatment, rapid increases in peripheral blood EBV DNA load diagnosed and predicted PTLD. In non-PTLD transplantation recipients, only 3.4% of the whole blood samples was above the cut-off value (P < .0001) despite heavy immune suppression and cytomegalovirus (CMV)-related disease. These findings illustrate the clinical importance of frequent EBV DNA load monitoring in LTx recipients. The increased EBV DNA loads in PTLD patients were restricted to the cellular blood compartment, as parallel serum samples were all below cut-off value, which indicates absence of lytic viral replication. EBV+ cells in PTLD patients have a very short doubling time, which can be as low as 56 hours, thereby creating the need for high screening frequency in high-risk patients. Furthermore, it is shown that EBV and CMV can reactivate independently in LTx recipients and that EBV DNA load monitoring may be useful in discriminating PTLD from rejection.


2016 ◽  
Vol 60 (3) ◽  
pp. 644-648 ◽  
Author(s):  
Amanda M. MacDonald ◽  
Claire M. Jardine ◽  
G. Douglas Campbell ◽  
Nicole M. Nemeth

Sign in / Sign up

Export Citation Format

Share Document